Human trial
Primary evidence or regulator source
123 elderly hip-fracture patients
Reported findings. IGF-I and one gait measure improved
Nonresponse. Most functional measures did not improve
Harms. Stopped early after congestive-heart-failure signal
Limits. No transfer to other routes/formulations/indications; clinician review pending.
Preparation: Ibutamoren mesylate MK-0677 Route: oral
Read original source ↗Editorial review 2026-10-09. Clinician review pending.